Healthcare Sector Ideas

[gfp927z]

>>> Remdesivir -


https://en.wikipedia.org/wiki/Remdesivir


Remdesivir (development code GS-5734) is a novel antiviral drug in the class of nucleotide analogs. Remdesivir is an adenosine analogue, which incorporates into nascent viral RNA chains and causes their premature termination. It was developed by Gilead Sciences as a treatment for Ebola virus disease and Marburg virus infections,[1] though it subsequently was found to show antiviral activity against other single stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus, and the coronaviruses (including MERS and SARS viruses).[2][3][4]

It is currently being studied for SARS-CoV-2 and Henipavirus infections.[5][6][7] Based on success against other coronavirus infections, Gilead provided remdesivir to physicians who treated an American patient in Snohomish County, Washington in 2020, who was infected with SARS-CoV-2,[8] and is providing the compound to China to conduct a pair of trials in infected individuals with and without severe symptoms

<<<